BioCorRx (BICX) Accumulated Expenses (2015 - 2026)

BioCorRx has reported Accumulated Expenses for 5 years, with the latest figure at $1652.0 in Q2 2022.

• Quarterly Accumulated Expenses rose 452.51% year-over-year to $1652.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $1652.0 (up 452.51% YoY) and the FY2021 annual result came in at $983.0, up 449.16% from the prior year.
• Accumulated Expenses advanced to $1652.0 in Q2 2022 per BICX's latest filing, from $1292.0 in the prior quarter.
• Over five years, Accumulated Expenses peaked at $1652.0 in Q2 2022 and troughed at $36.0 in Q2 2020.
• A 3-year average of $649.71 and a median of $299.0 in 2021 frame the typical range for Accumulated Expenses.
• The widest YoY moves for Accumulated Expenses: up 730.56% in 2021, down 449.16% in 2021.
• Over 3 years, Accumulated Expenses stood at $179.0 in 2020, then soared by 449.16% to $983.0 in 2021, then soared by 68.06% to $1652.0 in 2022.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $1652.0, $1292.0, and $983.0 for Q2 2022, Q1 2022, and Q4 2021 respectively.